Lars Lang Lehrskov
Novo Nordisk (Denmark)(DK)
Publications by Year
Research Areas
Diabetes Management and Research, Diabetes Treatment and Management, Gallbladder and Bile Duct Disorders, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Pancreatic function and diabetes
Most-Cited Works
- → Fluorescence or X-ray cholangiography in elective laparoscopic cholecystectomy: a randomized clinical trial(2020)84 cited
- → Pharmacokinetic and Pharmacodynamic Characteristics of Insulin Icodec After Subcutaneous Administration in the Thigh, Abdomen or Upper Arm in Individuals with Type 2 Diabetes Mellitus(2023)30 cited
- → Tumour necrosis factor‐alpha infusion produced insulin resistance but no change in the incretin effect in healthy volunteers(2013)24 cited
- → The Effects of TNF-α on GLP-1-Stimulated Plasma Glucose Kinetics(2015)19 cited
- Fluorescence versus X-ray cholangiography during laparoscopic cholecystectomy: protocol for a randomised trial.(2016)
- → Glycaemic Control in People with Type 2 Diabetes Treated with Insulin Degludec: A Real-World, Prospective Non-interventional Study—UPDATES Saudi Arabia(2022)3 cited
- Colonoscopy results are not enhanced by use of magnet endoguide in specialist practice.(2013)
- → Insulin Degludec in People with Type 2 Diabetes in China: A Non-interventional, Retrospective Chart Review Study (CN-TREAT)(2024)2 cited
- → Similar hypoglycemia duration with once-weekly icodec versus degludec or glargine U100 in insulin-treated T2D: a post hoc CGM analysis from ONWARDS 2 & 4(2024)
- → Continuous glucose monitoring in insulin-experienced individuals with type 2 diabetes switched to once-weekly insulin icodec versus once-daily comparators in ONWARDS 2 and 4: post-hoc analysis(2023)